Corporate Overview

HLS is a pharmaceutical company focused on the acquisition and commercialization of late-stage development or commercial-stage products in the United States and Canadian markets. HLS's current products focus on addressing unmet needs in the treatment of psychiatric disorders and cardiovascular disease. HLS's management team is composed of seasoned pharmaceutical executives with a strong track record of success in these therapeutic areas and at managing products in each of these lifecycle stages.

Learn More

Why Invest

Stable cash flow generation

Significant organic growth potential

Near-term operational catalysts to drive profitability

Profitable growth unlocks expansion opportunities

Latest News

View All News

Featured Presentation

Latest Events

View All Events

Latest Financial Results

View All Financial Reports